Literature DB >> 18698330

Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction.

Akihiko Taguchi1, Nami Nakagomi, Tomohiro Matsuyama, Akie Kikuchi-Taura, Hiroo Yoshikawa, Yukiko Kasahara, Haruka Hirose, Hiroshi Moriwaki, Takayuki Nakagomi, Toshihiro Soma, David M Stern, Hiroaki Naritomi.   

Abstract

Increasing evidence points to a role for circulating endothelial progenitors, including populations of CD34-positive (CD34(+)) cells present in peripheral blood, in vascular homeostasis and neovascularization. In this report, circulating CD34(+) cells in individuals with a history of cerebral infarction were correlated with changes in neurologic function over a period of 1 year. Patients with decreased levels of CD34(+) cells displayed significant worsening in neurologic function, evaluated by the Barthel Index and Clinical Dementia Rating. These results support the hypothesis that levels of circulating CD34(+) cells have prognostic value for neural function, consistent with their potential role in maintaining cerebral circulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698330     DOI: 10.1038/jcbfm.2008.92

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  13 in total

1.  Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke.

Authors:  Lixia Xue; Hao Chen; Ting Zhang; Jingjiong Chen; Zhi Geng; Yuwu Zhao
Journal:  Metab Brain Dis       Date:  2017-01-16       Impact factor: 3.584

2.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

3.  CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice.

Authors:  Jianping Wang; Xi Liu; Hong Lu; Chao Jiang; Xiaobing Cui; Lie Yu; Xiaojie Fu; Qian Li; Jian Wang
Journal:  Brain Behav Immun       Date:  2014-12-16       Impact factor: 7.217

4.  Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Famela Ramos; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2010-04-08       Impact factor: 5.531

Review 5.  Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell.

Authors:  Deepaneeta Sarmah; Harpreet Kaur; Jackson Saraf; Kanta Pravalika; Avirag Goswami; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Transl Stroke Res       Date:  2017-10-26       Impact factor: 6.829

6.  Transplantation of cryopreserved human umbilical cord blood mononuclear cells does not induce sustained recovery after experimental stroke in spontaneously hypertensive rats.

Authors:  Gesa Weise; Marlene Lorenz; Claudia Pösel; Ute Maria Riegelsberger; Veronika Störbeck; Manja Kamprad; Alexander Kranz; Daniel-Christoph Wagner; Johannes Boltze
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-30       Impact factor: 6.200

7.  Reduced ischemic brain injury by partial rejuvenation of bone marrow cells in aged rats.

Authors:  Akihiko Taguchi; Pengxiang Zhu; Fang Cao; Akie Kikuchi-Taura; Yukiko Kasahara; David M Stern; Toshihiro Soma; Tomohiro Matsuyama; Ryuji Hata
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-22       Impact factor: 6.200

8.  Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.

Authors:  Akihiko Taguchi; Chiaki Sakai; Toshihiro Soma; Yukiko Kasahara; David M Stern; Katsufumi Kajimoto; Masafumi Ihara; Takashi Daimon; Kenichi Yamahara; Kaori Doi; Nobuo Kohara; Hiroyuki Nishimura; Tomohiro Matsuyama; Hiroaki Naritomi; Nobuyuki Sakai; Kazuyuki Nagatsuka
Journal:  Stem Cells Dev       Date:  2015-08-17       Impact factor: 3.272

9.  The level of circulating endothelial progenitor cell is associated with cerebral vasoreactivity: a pilot study.

Authors:  Chih-Ping Chung; Po-Hsun Huang; Jia-Shiong Chen; Jaw-Wen Chen; Kuang-Yao Yang
Journal:  Biomed Res Int       Date:  2015-10-15       Impact factor: 3.411

10.  Endothelial progenitor cells in acute ischemic stroke.

Authors:  Joan Martí-Fàbregas; Javier Crespo; Raquel Delgado-Mederos; Sergi Martínez-Ramírez; Esther Peña; Rebeca Marín; Lavinia Dinia; Elena Jiménez-Xarrié; Ana Fernández-Arcos; Jesús Pérez-Pérez; Luis Querol; Marc Suárez-Calvet; Lina Badimon
Journal:  Brain Behav       Date:  2013-09-22       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.